Cleared Traditional

Sterile Hypodermic Needles for Single Use (K231720) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231720 · Wepon Medical Technology Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
87d
Days
Class 2
Risk

K231720 is an FDA 510(k) clearance for the Sterile Hypodermic Needles for Single Use. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Wepon Medical Technology Co., Ltd. (Wenling, CN). The FDA issued a Cleared decision on September 8, 2023 after a review of 87 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Wepon Medical Technology Co., Ltd. devices

Submission Details

510(k) Number K231720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2023
Decision Date September 08, 2023
Days to Decision 87 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 129d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 196
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K231720.
MESORAM® Hypodermic Needle (710301)
K230070 · Promamedical, Inc. · Oct 2023
Insulin Pen Needle
K230043 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Sep 2023
VitreJect® Needle
K230959 · Ocuject, LLC · Sep 2023
Sterile Safety Hypodermic Needles for Single Use
K231723 · Wepon Medical Technology Co., Ltd. · Sep 2023
Sterile syringes for single use with/without needle
K231729 · Wepon Medical Technology Co., Ltd. · Sep 2023
NovoFine® Plus
K231255 · Novo Nordisk, Inc. · Aug 2023